Hulica Capsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Hubist Pharmaceutical Co., Ltd.
MFDS item code 201907779 · Approved 2019.11.06
This product's status changed to Expired on 2024.11.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of peripheral and central neuropathic pain, adjunctive therapy for partial seizures, improvement of fibromyalgia
This medication is used for the treatment of peripheral and central neuropathic pain in adults. It is also utilized as an adjunct in patients with epilepsy experiencing partial seizures and can be effective even when secondary general symptoms are not present in some patients. Additionally, it helps alleviate symptoms of fibromyalgia. In other words, it is used to improve neuralgia, epilepsy, and myalgia.
This medication is administered orally, divided into two doses per day, irrespective of meals. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose is 150 mg per day, may increase to 300 mg per day after 3-7 days, and can be further increased at 7-day intervals to a maximum of 600 mg per day if necessary. - Central neuropathic pain: Starting dose is 150 mg per day, may increase to 300 mg per day after 1 week, and then further as needed.
The safety and efficacy of this medication have not been established in children under 12 years of age and adolescents aged 12 to 17; therefore, its use is not recommended.
This medication may increase the risk of suicidal thoughts or behaviors; therefore, if you notice any abnormal changes in mood or behavior while taking it, you should consult a doctor immediately. Individuals allergic to pregabalin or any ingredient of this medication should not take it, and caution is also necessary for patients with lactose intolerance. Diabetic patients may need to adjust the dosage of blood glucose-controlling medication due to weight gain, so they should consult with their doctor. If symptoms of angioedema occur, stop taking the medication immediately and notify medical personnel. Elderly patients should be especially cautious at the beginning of treatment as they are at a higher risk of falling due to dizziness or drowsiness. Notify a doctor if you experience blurred vision or changes in eyesight, as discontinuing the medication may improve the symptoms. Abrupt discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so dosage adjustments should be made according to a doctor's instructions. As there is a risk of drug abuse, patients with mental health issues or a history of drug abuse must consult before administration. Patients with decreased renal function may require dosage adjustments. Patients with heart disease should exercise caution when taking this medication, especially those with heart failure who should discuss it with their doctor. When taken with opioid analgesics, the risk of central nervous system depression may increase, so caution is advised. Patients with respiratory or nervous system diseases, kidney disorders, and elderly patients may face a risk of severe respiratory depression, necessitating potential dose adjustments. During early pregnancy, there is a risk of fetal malformations; therefore, women who are pregnant or planning to become pregnant should discuss with their doctor before taking this medication and should use effective birth control. Breastfeeding women should consult their doctor about whether to discontinue breastfeeding or the medication since this drug can pass into breast milk and affect the child. Before driving or operating hazardous machinery, ensure that this medication does not cause dizziness or drowsiness. Severe skin reactions may rarely occur; if any abnormal skin symptoms arise, stop taking the medication immediately and inform your physician. In case of overdose, symptoms such as mental confusion, drowsiness, and depression may occur, and treatment such as dialysis may be necessary.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough and fever, yellowing of skin or eyes (jaundice), profound lethargy, sudden and severe headaches, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is between 15°C and 30°C. This will help maintain the safety and efficacy of the drug.
Hard capsule with brown upper and white lower parts containing white powder
30 capsules/bottle, 60 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pregabalin 75mg
Hard capsule · Prescription medication
Hubist Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.